price should be double ($8) where it is now if good resultsif they release good results from their current trial, this should trade at a multiple of where it is now compared to other biotech companies in the US and it does trade on Nasdaq under EPIX. I think institutional investors are waiting (and rightly so) till the results are released before putting to their portfolio. That's when its true value will be recognized. Trading above $5 also means more institutions will be able to purchase it. I wouldn't be in a rush to sell IF the results are good as institutions will need a few days to review the results and start their buying.
I'll be adding to my position IF the results are good knowing that once institutions start buying it will take them several days to accumulate their position.
Good luck and let's hope for great results - it has been a long wait but hopefully worth it!